Literature DB >> 11124960

The human VPAC1 receptor: three-dimensional model and mutagenesis of the N-terminal domain.

L Lins1, A Couvineau, C Rouyer-Fessard, P Nicole, J J Maoret, M Benhamed, R Brasseur, A Thomas, M Laburthe.   

Abstract

The human VPAC(1) receptor for vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide belongs to the class II family of G-protein-coupled receptors with seven transmembrane segments. Like for all class II receptors, the extracellular N-terminal domain of the human VPAC(1) receptor plays a predominant role in peptide ligand recognition. To determine the three-dimensional structure of this N-terminal domain (residues 1-144), the Protein Data Bank (PDB) was screened for a homologous protein. A subdomain of yeast lipase B was found to have 27% sequence identity and 50% sequence homology with the N-terminal domain (8) of the VPAC(1) receptor together with a good alignment of the hydrophobic clusters. A model of the N-terminal domain of VPAC(1) receptor was thus constructed by homology. It indicated the presence of a putative signal sequence in the N-terminal extremity. Moreover, residues (Glu(36), Trp(67), Asp(68), Trp(73), and Gly(109)) which were shown to be crucial for VIP binding are gathered around a groove that is essentially negatively charged. New putatively important residues for VIP binding were suggested from the model analysis. Site-directed mutagenesis and stable transfection of mutants in CHO cells indicated that Pro(74), Pro(87), Phe(90), and Trp(110) are indeed important for VIP binding and activation of adenylyl cyclase activation. Combination of molecular modeling and directed mutagenesis provided the first partial three-dimensional structure of a VIP-binding domain, constituted of an electronegative groove with an outspanning tryptophan shell at one end, in the N-terminal extracellular region of the human VPAC(1) receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11124960     DOI: 10.1074/jbc.M009730200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.

Authors:  Ingrid Nachtergael; Pascale Vertongen; Ingrid Langer; Jason Perret; Patrick Robberecht; Magali Waelbroeck
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics.

Authors:  Emilie Ceraudo; Samuel Murail; Yossan-Var Tan; Jean-Jacques Lacapère; Jean-Michel Neumann; Alain Couvineau; Marc Laburthe
Journal:  Mol Endocrinol       Date:  2007-09-20

3.  Identification of a small molecule that simultaneously suppresses virulence and antibiotic resistance of Pseudomonas aeruginosa.

Authors:  Qiaoyun Guo; Yu Wei; Bin Xia; Yongxin Jin; Chang Liu; Xiaolei Pan; Jing Shi; Feng Zhu; Jinlong Li; Lei Qian; Xinqi Liu; Zhihui Cheng; Shouguang Jin; Jianping Lin; Weihui Wu
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

4.  Multiple C2 domains and transmembrane region proteins (MCTPs) tether membranes at plasmodesmata.

Authors:  Marie L Brault; Jules D Petit; Françoise Immel; William J Nicolas; Marie Glavier; Lysiane Brocard; Amèlia Gaston; Mathieu Fouché; Timothy J Hawkins; Jean-Marc Crowet; Magali S Grison; Véronique Germain; Marion Rocher; Max Kraner; Vikram Alva; Stéphane Claverol; Andrea Paterlini; Ykä Helariutta; Magali Deleu; Laurence Lins; Jens Tilsner; Emmanuelle M Bayer
Journal:  EMBO Rep       Date:  2019-07-09       Impact factor: 8.807

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.